• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞的比值是子宫内膜癌的一个预测指标。

The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer.

作者信息

Dong Yangyang, Cheng Yuan, Wang Jianliu

机构信息

Peking University People's Hospital, Beijing, China.

出版信息

Open Life Sci. 2019 Apr 6;14:110-118. doi: 10.1515/biol-2019-0012. eCollection 2019 Jan.

DOI:10.1515/biol-2019-0012
PMID:33817142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7874757/
Abstract

OBJECTIVE

The aim of our study was to assess the prognostic value of the ratio of neutrophil to lymphocyte (NLR) for patients with surgically treated endometrial cancer (EC).

METHODS

We retrospectively reviewed 510 EC patients who were surgically treated between January 2010 and December 2016. We used receiver-operating characteristic (ROC) curve analysis to identify an optimal cut-off for NLR in predicting overall survival (OS), cancer-specific survival (CSS) and disease-free survival (DFS). Nonparametric tests were used to determine the associations between NLR and clinicopathologic characteristics. The Kaplan-Meier method and Cox proportional-hazards regression were used for survival analysis.

RESULTS

With a cut-off of 2.47, the 510 patients were divided into low NLR (NLR <2.47) and high NLR (NLR ≥2.47). Elevated NLR was associated with advanced stage (P=0.039), increased histology grade (P=0.005) and lymph node metastasis (P=0.041). Multivariable analysis suggested that NLR was an independent prognostic marker for OS (hazard ratio [HR] 4.7; 95% confidence interval [CI], 1.5-14.1; P =0.006), CSS (HR 3.6; 95% CI, 1.1-11.5; P =0.028) and DFS (HR 2.3; 95% CI, 1.0-5.2; P =0.044).

CONCLUSION

NLR may be an independent prognostic indicator for OS, CSS and DFS. It could help clinicians with preoperative risk stratification and treatment strategy tailoring.

摘要

目的

本研究旨在评估中性粒细胞与淋巴细胞比值(NLR)对接受手术治疗的子宫内膜癌(EC)患者的预后价值。

方法

我们回顾性分析了2010年1月至2016年12月期间接受手术治疗的510例EC患者。我们使用受试者操作特征(ROC)曲线分析来确定NLR预测总生存期(OS)、癌症特异性生存期(CSS)和无病生存期(DFS)的最佳临界值。采用非参数检验确定NLR与临床病理特征之间的关联。采用Kaplan-Meier法和Cox比例风险回归进行生存分析。

结果

以2.47为临界值,将510例患者分为低NLR组(NLR<2.47)和高NLR组(NLR≥2.47)。NLR升高与晚期(P=0.039)、组织学分级增加(P=0.005)和淋巴结转移(P=0.041)相关。多变量分析表明,NLR是OS(风险比[HR]4.7;95%置信区间[CI],1.5-14.1;P=0.006)、CSS(HR 3.6;95%CI,1.1-11.5;P=0.028)和DFS(HR 2.3;95%CI,1.0-5.2;P=0.044)的独立预后标志物。

结论

NLR可能是OS、CSS和DFS的独立预后指标。它可以帮助临床医生进行术前风险分层和制定治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16db/7874757/54a8efe5b9d5/biol-14-110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16db/7874757/54a8efe5b9d5/biol-14-110-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16db/7874757/54a8efe5b9d5/biol-14-110-g001.jpg

相似文献

1
The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer.中性粒细胞与淋巴细胞的比值是子宫内膜癌的一个预测指标。
Open Life Sci. 2019 Apr 6;14:110-118. doi: 10.1515/biol-2019-0012. eCollection 2019 Jan.
2
The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.血浆纤维蛋白原与中性粒细胞-淋巴细胞比值(F-NLR)的联合是可切除性非小细胞肺癌患者的预测因素。
J Cell Physiol. 2018 May;233(5):4216-4224. doi: 10.1002/jcp.26239. Epub 2017 Dec 26.
3
Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在转移性胃癌患者中的预后意义
Medicine (Baltimore). 2020 Mar;99(10):e19405. doi: 10.1097/MD.0000000000019405.
4
Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.术前炎症反应生物标志物在胃癌患者中的预后价值及预测模型的构建
J Transl Med. 2015 Feb 18;13:66. doi: 10.1186/s12967-015-0409-0.
5
The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.预后营养指数(PNI)和中性粒细胞与淋巴细胞比值(NLR)对铂类化疗治疗晚期非小细胞肺癌的预后价值。
Ann Palliat Med. 2020 May;9(3):967-978. doi: 10.21037/apm.2020.04.31. Epub 2020 Apr 21.
6
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.术前中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测子宫内膜癌患者的生存率。
Br J Cancer. 2015 Jul 14;113(2):311-20. doi: 10.1038/bjc.2015.200. Epub 2015 Jun 16.
7
[Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer].中性粒细胞与淋巴细胞比值对局部晚期结直肠癌患者预后的影响
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 May 25;20(5):550-554.
8
Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.术前中性粒细胞与淋巴细胞比值对可手术切除胰腺神经内分泌肿瘤的预后意义。
Med Sci Monit. 2017 Nov 23;23:5574-5588. doi: 10.12659/msm.907182.
9
Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.术前中性粒细胞与淋巴细胞比值可显著预测接受经尿道膀胱肿瘤切除术的非肌层浸润性膀胱癌患者的死亡率。
Oncotarget. 2017 Feb 21;8(8):12891-12901. doi: 10.18632/oncotarget.14179.
10
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein/Albumin Ratio in Luminal Breast Cancers With HER2-Negativity.中性粒细胞与淋巴细胞比值及C反应蛋白/白蛋白比值在HER2阴性的管腔型乳腺癌中的预后意义
Front Oncol. 2022 Mar 4;12:845935. doi: 10.3389/fonc.2022.845935. eCollection 2022.

引用本文的文献

1
Neutrophil to Lymphocyte Ratio a Prognostic Tool in Endometrial Cancer Among Classical Prognostic Factors.在经典预后因素中,中性粒细胞与淋巴细胞比值作为子宫内膜癌的一种预后工具。
Diagnostics (Basel). 2025 Aug 27;15(17):2172. doi: 10.3390/diagnostics15172172.
2
Prognostic and predictive significance of the pan-immune-inflammation value in endometrial cancer patients undergoing adjuvant therapy.接受辅助治疗的子宫内膜癌患者中全免疫炎症值的预后和预测意义
Rep Pract Oncol Radiother. 2025 Jun 7;30(2):202-209. doi: 10.5603/rpor.105859. eCollection 2025.
3
Significance of the neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, and platelet-lymphocyte ratio in peripheral blood for endometrial cancer.

本文引用的文献

1
Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis.中性粒细胞与淋巴细胞比值在自身免疫性脑炎诊断及病情进展中的预测作用
Neurosci Lett. 2019 Feb 16;694:129-135. doi: 10.1016/j.neulet.2018.12.003. Epub 2018 Dec 3.
2
Propensity score analysis of recurrence for neutrophil-to-lymphocyte ratio in colorectal cancer.结直肠癌中性粒细胞与淋巴细胞比值复发的倾向评分分析
J Surg Res. 2017 Nov;219:244-252. doi: 10.1016/j.jss.2017.05.109. Epub 2017 Jul 4.
3
Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer.
外周血中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值及血小板与淋巴细胞比值在子宫内膜癌中的意义
Am J Transl Res. 2024 Nov 15;16(11):6689-6698. doi: 10.62347/QNHR2387. eCollection 2024.
4
Hematologic inflammatory indexes as a prognostic factor in endometrial cancer grading and staging.血液学炎症指标作为子宫内膜癌分级和分期的预后因素
Caspian J Intern Med. 2023 Summer;14(3):443-448. doi: 10.22088/cjim.14.3.443.
5
Preoperative Prognostic Nutritional Index Is a Prognostic Indicator of Cancer-Specific Survival in Patients Undergoing Endometrial Cancer Surgery.术前预后营养指数是子宫内膜癌手术患者癌症特异性生存的预后指标。
J Korean Med Sci. 2023 May 29;38(21):e163. doi: 10.3346/jkms.2023.38.e163.
6
Study on Preoperative Neutrophil/Lymphocyte (NLR) and Platelet/Lymphocyte Ratio (PLR) as a Predictive Factor in Endometrial Cancer.术前中性粒细胞/淋巴细胞(NLR)和血小板/淋巴细胞比值(PLR)作为子宫内膜癌预测因子的研究。
Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3317-3322. doi: 10.31557/APJCP.2022.23.10.3317.
7
Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis.治疗前炎症参数可预测子宫内膜癌患者的生存情况:一项前瞻性数据库分析。
Gynecol Oncol. 2022 Jan;164(1):146-153. doi: 10.1016/j.ygyno.2021.11.009. Epub 2021 Nov 19.
8
Prognostic Implications of Immune-Related Genes' (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer.免疫相关基因(IRGs)特征模型在宫颈癌和子宫内膜癌中的预后意义
Front Genet. 2020 Jul 21;11:725. doi: 10.3389/fgene.2020.00725. eCollection 2020.
9
Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy.FIGO I-III期子宫内膜癌患者术后接受体外放疗的全身炎症因子分析及生存结局
J Clin Med. 2020 May 12;9(5):1441. doi: 10.3390/jcm9051441.
血小板计数与淋巴细胞单核细胞比值的联合是接受非小细胞肺癌手术患者的一个预后因素。
Oncotarget. 2017 Jun 1;8(42):73198-73207. doi: 10.18632/oncotarget.18336. eCollection 2017 Sep 22.
4
Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis.中性粒细胞与淋巴细胞比值是卵巢癌患者潜在的预后生物标志物:一项荟萃分析。
Biomed Res Int. 2017;2017:7943467. doi: 10.1155/2017/7943467. Epub 2017 Jul 26.
5
Neutrophils in cancer: prognostic role and therapeutic strategies.中性粒细胞与癌症:预后作用和治疗策略。
Mol Cancer. 2017 Aug 15;16(1):137. doi: 10.1186/s12943-017-0707-7.
6
The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值在膀胱癌患者中的临床应用:一项系统评价和荟萃分析。
Int J Clin Oncol. 2017 Oct;22(5):817-825. doi: 10.1007/s10147-017-1171-5. Epub 2017 Jul 27.
7
Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.治疗前血液中性粒细胞与淋巴细胞比值对晚期癌症幸存者预后的预测作用:66 项队列研究的系统评价和荟萃分析。
Cancer Treat Rev. 2017 Jul;58:1-13. doi: 10.1016/j.ctrv.2017.05.005. Epub 2017 May 29.
8
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.中性粒细胞与淋巴细胞比值对妇科癌症生存结局具有预后价值吗?一项系统评价与Meta分析。
Gynecol Oncol. 2017 Jun;145(3):584-594. doi: 10.1016/j.ygyno.2017.02.026. Epub 2017 Feb 20.
9
Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies.中性粒细胞与淋巴细胞比值在宫颈癌中的预后意义:一项观察性研究的系统评价和荟萃分析
Oncotarget. 2017 Mar 7;8(10):16755-16764. doi: 10.18632/oncotarget.15157.
10
The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review.中性粒细胞与淋巴细胞比值在结直肠癌中的预后价值:一项系统综述。
J Surg Oncol. 2017 Mar;115(4):470-479. doi: 10.1002/jso.24523. Epub 2017 Jan 20.